Impact of NSAIDs corticosteroids DMARDs biologics and their comparisons with natural products in C-reactive proteins (CRP) linked cardiovascular disorders

Ablij HC, Meinders AE (2002) C-reactive protein: history and revival. Eur J Intern Med 13(7):412–422

Article  CAS  PubMed  Google Scholar 

Agostinis-Sobrinho C, Vicente SE, Norkiene S, Rauckienė-Michaelsson A, Kievisienė J, Dubey VP, Razbadauskas A, Lopes L, Santos R (2022) Is the leptin/adiponectin ratio a better diagnostic biomarker for insulin resistance than leptin or adiponectin alone in adolescents? Children 9(8):1193

Article  PubMed  PubMed Central  Google Scholar 

Alfaddagh A, Martin SS, Leucker TM, Michos ED, Blaha MJ, Lowenstein CJ, Jones SR, Toth PP (2020) Inflammation and cardiovascular disease: From mechanisms to therapeutics. Am J Prevent Cardiol. 4:100130

Article  Google Scholar 

Altman R, Marcussen KC (2001) Effects of a ginger extract on knee pain in patients with osteoarthritis. Arthritis Rheum 44(11):2531–2538

Article  CAS  PubMed  Google Scholar 

Ammon HP (2006) Boswellic acids in chronic inflammatory diseases. Planta Med 72(12):1100–1116

Article  CAS  PubMed  Google Scholar 

Arici M, Walls J (2001) End-stage renal disease, atherosclerosis, and cardiovascular mortality: is C-reactive protein the missing link? Kidney Int 59(2):407–414

Article  CAS  PubMed  Google Scholar 

Azeez TB, Lunghar J (2021) Antiinflammatory effects of turmeric (Curcuma longa) and ginger (Zingiber officinale). Inflam Nat Prod 1:83–102

Google Scholar 

Badimon L, Peña E, Arderiu G, Padró T, Slevin M, Vilahur G, Chiva-Blanch G (2018) C-reactive protein in atherothrombosis and angiogenesis. Front Immunol 2(9):430. https://doi.org/10.3389/fimmu.2018.00430

Article  CAS  Google Scholar 

Bălănescu AR, Bojincă VC, Bojincă M, Donisan T, Bălănescu SM (2019) Cardiovascular effects of methotrexate in immune-mediated inflammatory diseases. Exp Ther Med 17(2):1024–1029

PubMed  Google Scholar 

Banait T, Wanjari A, Danade V, Banait S, Jain J (2022) Role of high-sensitivity C-reactive protein (Hs-CRP) in non-communicable diseases: a review. Cureus. https://doi.org/10.7759/cureus.30225

Article  PubMed  PubMed Central  Google Scholar 

Bansal T, Pandey A, Deepa D, Asthana AK (2014) C-reactive protein (CRP) and its association with periodontal disease: a brief review. J Clin Diagnos Res JCDR. https://doi.org/10.7860/JCDR/2014/8355.4646

Article  Google Scholar 

Basu A, Du M, Sanchez K, Leyva MJ, Betts NM, Blevins S, Wu M, Aston CE, Lyons TJ (2011) Green tea minimally affects biomarkers of inflammation in obese subjects with metabolic syndrome. Nutrition 27(2):206–213

Article  CAS  PubMed  PubMed Central  Google Scholar 

Berg AH, Scherer PE (2005) Adipose tissue, inflammation, and cardiovascular disease. Circ Res 96(9):939–949

Article  CAS  PubMed  Google Scholar 

Bharadwaj D, Stein MP, Volzer M, Mold C, Clos TW (1999) The major receptor for C-reactive protein on leukocytes is Fcγ receptor II. J Exp Med 190(4):585–590

Article  CAS  PubMed  PubMed Central  Google Scholar 

Biswas I, Khan GA (2020) Endothelial dysfunction in cardiovascular diseases. Basic Clin Underst Microcirc 22:10

Google Scholar 

Black S, Kushner I, Samols D (2004) C-reactive protein. J Biol Chem 279(47):48487–48490

Article  CAS  PubMed  Google Scholar 

Bogaty P, Brophy JM, Noel M, Boyer L, Simard S, Bertrand F, Dagenais GR (2004) Impact of prolonged cyclooxygenase-2 inhibition on inflammatory markers and endothelial function in patients with ischemic heart disease and raised C-reactive protein: a randomized placebo-controlled study. Circulation 110(8):934–939

Article  CAS  PubMed  Google Scholar 

Bøhn SK, Ward NC, Hodgson JM, Croft KD (2012) Effects of tea and coffee on cardiovascular disease risk. Food Funct 3(6):575–591

Article  PubMed  Google Scholar 

Boroumand N, Samarghandian S, Hashemy SI (2018) Immunomodulatory, anti-inflammatory, and antioxidant effects of curcumin. J Herbmed Pharmacol 7(4):211–219

Article  CAS  Google Scholar 

Brophy JM (2005) Celecoxib and cardiovascular risks. Expert Opin Drug Saf 4(6):1005–1015

Article  CAS  PubMed  Google Scholar 

Cannon CP, Chen C, Curtis SP, Viscusi J, Ahmed T, DiBattiste PM (2008) A comparison of cardiovascular biomarkers in patients treated for three months with etoricoxib, celecoxib, ibuprofen, and placebo. Arch Drug Inf 1(1):4–13

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cardoso IL, Paulos AT (2017) C reactive protein and cardiovascular disease. Int Arch Cardiovasc Dis 1(1):1–1

Google Scholar 

Catanzaro M, Corsini E, Rosini M, Racchi M, Lanni C (2018) Immunomodulators inspired by nature: a review on curcumin and echinacea. Molecules 23(11):2778

Article  PubMed  PubMed Central  Google Scholar 

Chandran B, Goel A (2012) A randomized, pilot study to assess the efficacy and safety of curcumin in patients with active rheumatoid arthritis. Phytother Res 26(11):1719–1725

Article  CAS  PubMed  Google Scholar 

Chattopadhyay A (2020) The adverse effects of corticosteroids. Eur J Sports Exerc Sci 9(3):25–32

Google Scholar 

Choe JY, Kim SK (2015) Association between serum uric acid and inflammation in rheumatoid arthritis: perspective on lowering serum uric acid of leflunomide. Clin Chim Acta 1(438):29–34

Article  Google Scholar 

Ciprandi G, Cirillo I, Vizzaccaro A, Milanese M, Tosca MA (2004) Airway function and nasal inflammation in seasonal allergic rhinitis and asthma. Clin Exp Allergy 34(6):891–896. https://doi.org/10.1111/j.1365-2222.2004.01970.x

Article  CAS  PubMed  Google Scholar 

Clyne B, Olshaker JS (1999) The C-reactive protein. J Emerg Med 17(6):1019–1025

Article  CAS  PubMed  Google Scholar 

Cross M, Smith E, Hoy D, Carmona L, Wolfe F, Vos T, Williams B, Gabriel S, Lassere M, Johns N, Buchbinder R (2014) The global burden of rheumatoid arthritis: estimates from the global burden of disease 2010 study. Ann Rheum Dis 73(7):1316–1322

Article  PubMed  Google Scholar 

Dale J, Alcorn N, Capell H, Madhok R (2007) Combination therapy for rheumatoid arthritis: methotrexate and sulfasalazine together or with other DMARDs. Nat Clin Pract Rheumatol 3(8):450–458

Article  CAS  PubMed  Google Scholar 

Davies NM, McLachlan AJ, Day RO, Williams KM (2000) Clinical pharmacokinetics and pharmacodynamics of celecoxib: a selective cyclo-oxygenase-2 inhibitor. Clin Pharmacokinet 38:225–242

Article  CAS  PubMed  Google Scholar 

DeMizio DJ, Geraldino-Pardilla LB (2020) Autoimmunity and inflammation link to cardiovascular disease risk in rheumatoid arthritis. Rheumatol Therapy 7(1):19–33

Article  Google Scholar 

Dessein PH, Joffe BI, Singh S (2005) Biomarkers of endothelial dysfunction, cardiovascular risk factors and atherosclerosis in rheumatoid arthritis. Arthritis Res Ther 7:1

Article  Google Scholar 

Dixit KS, Kumthekar PU (2020) Optimal management of corticosteroids in patients with intracranial malignancies. Curr Treat Options Oncol 21:1–1

Article  Google Scholar 

Du Clos TW (2000) Function of C-reactive protein. Ann Med 32(4):274–278

Article  PubMed  Google Scholar 

Eklund CM (2009) Proinflammatory cytokines in CRP baseline regulation. Adv Clin Chem 1(48):111–136

Article 

Comments (0)

No login
gif